GS-4059
Showing 1 - 25 of 273
Relapsed/Refractory B-cell Malignancies Trial in France, United Kingdom (Tirabrutinib)
Completed
- Relapsed/Refractory B-cell Malignancies
-
Lille, Nord, France
- +5 more
Mar 23, 2022
Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Entospletinib, Obinutuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Tirabrutinib
- +2 more
-
Aschaffenburg, Germany
- +14 more
Dec 17, 2021
Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)
Completed
- Non Hodgkins Lymphoma
- Chronic Lymphocytic Leukaemia
-
Lille, France
- +5 more
Feb 22, 2021
Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Idelalisib, Obinutuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Tirabrutinib
- +2 more
-
Frankfurt, Brandenburg, Germany
- +13 more
Dec 24, 2021
Rheumatoid Arthritis Trial in United States (Tirabrutinib, Placebo)
Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- GS-0272
- Placebo
- (no location specified)
Sep 4, 2023
Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))
Enrolling by invitation
- Alcohol Consumption
- Control
- +2 more
-
Palo Alto, CaliforniaStanford University
May 8, 2023
Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)
Not yet recruiting
- Chronic Hepatitis B
- GS-2829
- +3 more
- (no location specified)
Mar 14, 2023
Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))
Not yet recruiting
- Genetic Predisposition
- Next-Generation Sequencing (NGS)
-
Tübingen, GermanyUniversity Hospital Tübingen
Sep 22, 2023
Gastroschisis Trial in Houston (fetoscopy)
Recruiting
- Gastroschisis
- fetoscopy
-
Houston, TexasTexas Children's Hospital
Jan 20, 2023
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
STEMI - ST Elevation Myocardial Infarction Trial
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- (no location specified)
Dec 24, 2022
HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)
Active, not recruiting
- HIV-1 Infection
- Oral Lenacapavir
- +3 more
-
Los Angeles, California
- +22 more
Nov 4, 2022
Stroke Trial in Venice (real tACS, sham tACS)
Recruiting
- Stroke
- real tACS
- sham tACS
-
Venice, ItalyIRCCS San Camillo Hospital
Apr 13, 2023
Sexual Health Trial in Taoyuan (Received the GS-SHEP)
Completed
- Sexual Health
- Received the GS-SHEP
-
Taoyuan, Guishan Dist., TaiwanCheng Gung Memorial Hospital
Mar 5, 2023
Cutaneous Lupus Erythematosus Trial in United States (GS-5718, Placebo)
Terminated
- Cutaneous Lupus Erythematosus
- GS-5718
- Placebo
-
Beverly Hills, California
- +4 more
Nov 17, 2022